Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution

  title={Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution},
  author={Mark Shackleton and Elsa Quintana and Eric R. Fearon and Sean J. Morrison},

Figures and Tables from this paper

Cancer stem cells: impact, heterogeneity, and uncertainty.

Evolution of the cancer stem cell model.

Tumour heterogeneity and cancer cell plasticity

Studies using lineage tracing and deep sequencing could have implications for the cancer stem-cell model and may help to determine the extent to which it accounts for therapy resistance and disease progression.

The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets

The current understanding of Cancer Stem Cells is summarized, with a focus on the possibility to identify specific markers of CSCs, and the clinical application of targeting C SCs for cancer treatment is discussed.

Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes

The main molecular markers that have been identified as being able to recognise C SCs in breast carcinomas are described, the major molecular pathways that regulate CSCs and their association with the different molecular subtypes are described.

Cancer Stem Cells: From Birth to Death

This cancer subpopulation is inherently resistant to anticancer therapeutics, and its targeting could avoid metastatic disease, which is largely incurable, and clinical relapses.

Overview: Cancer Stem Cell and Tumor Environment

The cutting-edge progress regarding LSC research and the promising clinical strategies with LSC-targeted therapy are described.

Cancer stem cells renew their impact

The cancer stem cell (CSC) concept has provocative implications for our understanding of cancer biology and therapy. Its clinical relevance now receives a major boost from the finding that a stem

Cancer stem cells: small subpopulation or evolving fraction?

  • H. Enderling
  • Biology
    Integrative biology : quantitative biosciences from nano to macro
  • 2015
Central to the debate about cancer stem cells in solid tumors is the proportion of cells that can initiate, propagate, and re-initiate tumors. An initially assumed minor subpopulation is confronted

Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy

Although the field of CSC biology is relatively young, continued elucidation of the features of these cells holds promise for the development of novel patient therapies.



Stem cell concepts renew cancer research.

This review provides a historical overview of the influence of hematology on the development of stem cell concepts and their linkage to cancer.

Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells

It is suggested that the low frequency of tumor-sustaining cells observed in xenotransplantation studies may reflect the limited ability of human tumor cells to adapt to growth in a foreign (mouse) milieu.

The clonal evolution of tumor cell populations.

Each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment, which should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.

Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells"

A large number of xenotransplant experiments supporting the cancer stem cell (CSC) hypothesis found similar L-IC frequencies in genetically comparable leukemias using syngeneic or xenogeneic models.

Curing metastatic cancer: lessons from testicular germ-cell tumours

Why are TGCTs more sensitive to chemotherapeutics than most other tumour types?

Stem cells, cancer, and cancer stem cells

Stem cell biology has come of age. Unequivocal proof that stem cells exist in the haematopoietic system has given way to the prospective isolation of several tissue-specific stem and progenitor

Isolation and Molecular Characterization of Cancer Stem Cells in MMTV‐Wnt‐1 Murine Breast Tumors

These studies suggest that there is a cancer stem cell compartment in the MMTV‐Wnt‐1 murine breast tumor and thatthere is a clinical utility of this model for the study of cancer stem cells.

Phenotypic characterization of human colorectal cancer stem cells

The results validate the stem cell working model in human CRC and provide a highly robust surface marker profile for CRC stem cell isolation.

Identification and expansion of human colon-cancer-initiating cells

It is concluded that colorectal cancer is created and propagated by a small number of undifferentiated tumorigenic CD133+ cells, which should therefore be the target of future therapies.

Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

It is shown that leukaemia stem cells (LSC) can maintain the global identity of the progenitor from which they arose while activating a limited stem-cell- or self-renewal-associated programme.